(LIN) Linde Ordinary Shares - Overview

Sector: Basic Materials | Industry: Specialty Chemicals | Exchange: NASDAQ (USA) | Market Cap: 227.582m USD | Total Return: 7.2% in 12m

Stock Industrial Gases, Process Gases, Plant Construction
Total Rating 51
Risk 73
Buy Signal 0.29
Specialty Chemicals +12.7
Industrial Gases +3.4
Market Cap: 227,582m
Avg Trading Vol: 1.27B USD
ATR: 2.09%
Peers RS (IBD): 46.5
Risk 5d forecast
Volatility16.9%
Rel. Tail Risk-1.84%
Reward TTM
Sharpe Ratio0.27
Alpha0.97
Character TTM
Beta0.299
Beta Downside0.489
Drawdowns 3y
Max DD19.18%
CAGR/Max DD0.68
EPS (Earnings per Share) EPS (Earnings per Share) of LIN over the last years for every Quarter: "2021-03": 2.49, "2021-06": 2.7, "2021-09": 2.73, "2021-12": 2.77, "2022-03": 2.93, "2022-06": 3.1, "2022-09": 3.1, "2022-12": 3.16, "2023-03": 3.42, "2023-06": 3.57, "2023-09": 3.63, "2023-12": 3.59, "2024-03": 3.75, "2024-06": 3.85, "2024-09": 3.94, "2024-12": 3.97, "2025-03": 3.95, "2025-06": 4.09, "2025-09": 4.21, "2025-12": 4.2, "2026-03": 0,
EPS CAGR: -44.98%
EPS Trend: -24.5%
Last SUE: -4.00
Qual. Beats: 0
Revenue Revenue of LIN over the last years for every Quarter: 2021-03: 7243, 2021-06: 7584, 2021-09: 7668, 2021-12: 8298, 2022-03: 8211, 2022-06: 8457, 2022-09: 8797, 2022-12: 7899, 2023-03: 8193, 2023-06: 8204, 2023-09: 8155, 2023-12: 8302, 2024-03: 8100, 2024-06: 8267, 2024-09: 8356, 2024-12: 8282, 2025-03: 8112, 2025-06: 8495, 2025-09: 8615, 2025-12: 8764, 2026-03: null,
Rev. CAGR: 1.75%
Rev. Trend: 30.1%
Last SUE: 0.76
Qual. Beats: 0
Description: LIN Linde Ordinary Shares March 05, 2026

Linde plc (LIN) is an industrial gas company operating across diverse global markets, including the US, China, and Germany.

The company produces and distributes atmospheric gases like oxygen and nitrogen, and process gases such as hydrogen and carbon dioxide. Industrial gas companies often rely on long-term supply contracts with customers, providing revenue stability.

Linde also designs and constructs industrial plants, including air separation and natural gas facilities, for both internal use and third-party clients. This business model segment provides specialized engineering services in addition to gas production.

Linde serves a wide variety of sectors, including healthcare, chemicals, manufacturing, and electronics. This diversified customer base helps mitigate risk associated with downturns in any single industry.

To further understand Lindes market position and financial health, consider exploring its detailed financials on ValueRay.

Headlines to Watch Out For
  • Industrial gas demand from manufacturing and healthcare sectors drives revenue
  • Energy costs directly impact production expenses and profitability
  • Global economic slowdown reduces industrial gas consumption
  • Regulatory changes in environmental standards affect operating costs
  • Expansion into emerging markets boosts long-term growth prospects
Piotroski VR‑10 (Strict, 0-10) 6.5
Net Income: 6.94b TTM > 0 and > 6% of Revenue
FCF/TA: 0.06 > 0.02 and ΔFCF/TA -0.28 > 1.0
NWC/Revenue: -5.51% < 20% (prev -4.84%; Δ -0.67% < -1%)
CFO/TA 0.12 > 3% & CFO 10.35b > Net Income 6.94b
Net Debt (21.93b) to EBITDA (12.91b): 1.70 < 3
Current Ratio: 0.88 > 1.5 & < 3
Outstanding Shares: last quarter (468.7m) vs 12m ago -2.12% < -2%
Gross Margin: 43.33% > 18% (prev 0.37%; Δ 4.30k% > 0.5%)
Asset Turnover: 40.71% > 50% (prev 41.18%; Δ -0.47% > 0%)
Interest Coverage Ratio: 33.62 > 6 (EBITDA TTM 12.91b / Interest Expense TTM 272.0m)
Altman Z'' 1.45
A: -0.02 (Total Current Assets 13.32b - Total Current Liabilities 15.20b) / Total Assets 86.82b
B: 0.19 (Retained Earnings 16.61b / Total Assets 86.82b)
C: 0.11 (EBIT TTM 9.14b / Avg Total Assets 83.48b)
D: 0.22 (Book Value of Equity 10.38b / Total Liabilities 47.08b)
Altman-Z'' Score: 1.45 = BB
Beneish M -3.18
DSRI: 1.00 (Receivables 5.24b/5.06b, Revenue 33.99b/33.01b)
GMI: 0.84 (GM 43.33% / 36.61%)
AQI: 1.01 (AQ_t 0.52 / AQ_t-1 0.52)
SGI: 1.03 (Revenue 33.99b / 33.01b)
TATA: -0.04 (NI 6.94b - CFO 10.35b) / TA 86.82b)
Beneish M-Score: -3.18 (Cap -4..+1) = AA
What is the price of LIN shares? As of April 02, 2026, the stock is trading at USD 495.76 with a total of 2,760,454 shares traded.
Over the past week, the price has changed by +0.30%, over one month by -2.72%, over three months by +15.47% and over the past year by +7.15%.
Is LIN a buy, sell or hold? Linde Ordinary Shares has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy LIN.
  • StrongBuy: 12
  • Buy: 6
  • Hold: 9
  • Sell: 0
  • StrongSell: 1
What are the forecasts/targets for the LIN price?
ISSUER TARGET UP/DOWN
Wallstreet Target Price 513.9 3.6%
Analysts Target Price 513.9 3.6%
LIN Fundamental Data Overview March 31, 2026
P/E Trailing = 33.6614
P/E Forward = 27.3224
P/S = 6.6963
P/B = 5.9147
P/EG = 2.293
Revenue TTM = 33.99b USD
EBIT TTM = 9.14b USD
EBITDA TTM = 12.91b USD
Long Term Debt = 20.68b USD (from longTermDebt, last quarter)
Short Term Debt = 6.31b USD (from shortTermDebt, last quarter)
Debt = 26.99b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 21.93b USD (from netDebt column, last quarter)
Enterprise Value = 249.52b USD (227.58b + Debt 26.99b - CCE 5.06b)
Interest Coverage Ratio = 33.62 (Ebit TTM 9.14b / Interest Expense TTM 272.0m)
EV/FCF = 49.03x (Enterprise Value 249.52b / FCF TTM 5.09b)
FCF Yield = 2.04% (FCF TTM 5.09b / Enterprise Value 249.52b)
FCF Margin = 14.97% (FCF TTM 5.09b / Revenue TTM 33.99b)
Net Margin = 20.42% (Net Income TTM 6.94b / Revenue TTM 33.99b)
Gross Margin = 43.33% ((Revenue TTM 33.99b - Cost of Revenue TTM 19.26b) / Revenue TTM)
Gross Margin QoQ = 48.12% (prev 38.02%)
Tobins Q-Ratio = 2.87 (Enterprise Value 249.52b / Total Assets 86.82b)
Interest Expense / Debt = 0.24% (Interest Expense 64.0m / Debt 26.99b)
Taxrate = 23.92% (481.0m / 2.01b)
NOPAT = 6.96b (EBIT 9.14b * (1 - 23.92%))
Current Ratio = 0.88 (Total Current Assets 13.32b / Total Current Liabilities 15.20b)
Debt / Equity = 0.71 (Debt 26.99b / totalStockholderEquity, last quarter 38.24b)
Debt / EBITDA = 1.70 (Net Debt 21.93b / EBITDA 12.91b)
Debt / FCF = 4.31 (Net Debt 21.93b / FCF TTM 5.09b)
Total Stockholder Equity = 38.35b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.31% (Net Income 6.94b / Total Assets 86.82b)
RoE = 18.10% (Net Income TTM 6.94b / Total Stockholder Equity 38.35b)
RoCE = 15.49% (EBIT 9.14b / Capital Employed (Equity 38.35b + L.T.Debt 20.68b))
RoIC = 10.87% (NOPAT 6.96b / Invested Capital 64.03b)
WACC = 6.30% (E(227.58b)/V(254.57b) * Re(7.03%) + D(26.99b)/V(254.57b) * Rd(0.24%) * (1-Tc(0.24)))
Discount Rate = 7.03% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: -100.0 | Cagr: -2.02%
[DCF] Terminal Value 84.61% ; FCFF base≈5.02b ; Y1≈4.81b ; Y5≈4.68b
[DCF] Fair Price = 226.9 (EV 127.09b - Net Debt 21.93b = Equity 105.16b / Shares 463.4m; r=6.30% [WACC]; 5y FCF grow -5.61% → 3.0% )
EPS Correlation: -24.47 | EPS CAGR: -44.98% | SUE: -4.0 | # QB: 0
Revenue Correlation: 30.07 | Revenue CAGR: 1.75% | SUE: 0.76 | # QB: 0
EPS next Quarter (2026-06-30): EPS=4.45 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+2 | Analysts=17
EPS current Year (2026-12-31): EPS=17.82 | Chg7d=+0.003 | Chg30d=-0.010 | Revisions Net=+1 | Growth EPS=+8.3% | Growth Revenue=+4.7%
EPS next Year (2027-12-31): EPS=19.49 | Chg7d=+0.013 | Chg30d=+0.008 | Revisions Net=+1 | Growth EPS=+9.4% | Growth Revenue=+5.0%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.0% (Discount Rate 7.9% - Earnings Yield 3.0%)
[Growth] Growth Spread = -0.3% (Analyst 4.7% - Implied 5.0%)
Additional Sources for LIN Stock Fund Manager Positions: Dataroma · Stockcircle